DB
RNAM

Danske Bank’s Avidity Biosciences RNAM Stock Holding History

Danske Bank’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,900
Closed -$137K – 1493
2025
Q4 		$137K Buy
+1,900
New +$123K ﹤0.01% 716
2024
Q4 		– Sell
-1,000
Closed -$45.9K – 1609
2024
Q3 		$45.9K Buy
+1,000
New +$43.4K ﹤0.01% 1220

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

Danske Bank's RNAM Position: Q1 2026 in Review

Danske Bank sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 1,900 shares — an estimated $137K sold.

Danske Bank first reported a position in RNAM in Q3 2024 and held it in 2 quarters. The position peaked at $137K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Danske Bank reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Danske Bank sold 1,900 Avidity Biosciences shares in Q1 2026, an estimated $137K.
  • Danske Bank first reported a position in Avidity Biosciences in Q3 2024 and held it in 2 quarters.
  • Danske Bank's Avidity Biosciences position peaked at $137K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Danske Bank's 13F filing for Q1 2026, filed 12 May 2026.